Research published in JCI Insight describes tirzepatide as an "imbalanced and biased" dual agonist, meaning it shows equal affinity for the GIP receptor compared to native GIP but approximately 5-fold weaker affinity for the GLP-1 receptor compared to native GLP-1
Contact our office to set up a consultation.
Same patient, same heart disease, same drug covered with a diabetes code, not covered without one. The MTA described Healeys reversal on copays and deductibles as a huge victory for workers, retirees and their families
Beyer, Xiaoping Ruan, Emily Beebe, Libbey S
The highest dose outperformed liraglutide, which was notable because liraglutide was, at the time, a leading GLP-1 obesity treatment
Side effects were mostly mild #GI symptoms that improved over time